Financings

Moss Genomics Announces Closing of Financing Round

By The Northwire Desk — AI Analysis Nov 12, 2025 · 19:02 MOSS · 0.1 Moss Genomics Inc.

MOSS · Price

Moss Genomics closed a non‑brokered private placement of 555,555 common shares at $0.18 per share, generating gross proceeds of $100,000.
The company also issued 5,164,213 common shares as consideration for asset purchase agreements that acquired approximately 224.75 ETH at an average price of $3,833 per ETH (aggregate deemed consideration $966,435).
Following the transactions, Moss Genomics has a total of 63,414,545 common shares issued and outstanding; proceeds will be used for general working capital.

Private Placement: 555,555 common shares @ $0.18/share → Gross proceeds: $100,000 (no finder's fees).
Use of Proceeds: General working capital.
Asset Purchase Share Issuance: 5,164,213 common shares issued at a deemed price of $0.18/share as consideration for acquiring ~224.7523 ETH.
Consideration Value: Average ETH price $3,833 → Aggregate deemed consideration: $966,435.
Post‑transaction Share Count: 63,414,545 common shares issued and outstanding.
Hold Periods: All securities subject to applicable statutory hold periods under Canadian securities laws.
Annual & Special General Meeting (AGSM): Scheduled for November 13, 2025 (virtual).

(No executive quotes were included in the release.)

More from Moss Genomics Inc.